dapsone has been researched along with Inflammation in 21 studies
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dapsone exerts cardioprotective effects on doxorubicin-induced cardiotoxicity through its anti-inflammatory and antioxidant mechanism." | 7.96 | Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats. ( Dehpour, AR; Emami, AH; Faghir-Ghanesefat, H; Nezamoleslami, S; Sheibani, M, 2020) |
| "Phenotypic activity of these two routes of metabolism was assessed in 18 patients receiving longterm dapsone therapy for inflammatory dermatoses and was related to the development of dapsone toxicity." | 7.70 | Development of dapsone toxicity in patients with inflammatory dermatoses: activity of acetylation and hydroxylation of dapsone as risk factors. ( Adedoyin, A; Bluhm, RE; Branch, RA; McCarver, DG, 1999) |
| " BACKGROUND: Acne vulgaris has varying physical and psychological effects in men and women of different ages, races, and ethnicities." | 6.84 | Treatment Response With Once-Daily Topical Dapsone Gel, 7.5% for Acne Vulgaris: Subgroup Analysis of Pooled Data from Two Randomized, Double-Blind Stu. ( Berk, DR; Bruce, S; Chang-Lin, JE; Downie, J; Draelos, ZD; Kaoukhov, A; Kempers, SE; Peredo, MI; Rodriguez, DA; Ruan, S, 2017) |
| "Treatment with dapsone and metformin reversed the effects of testosterone in the DAP and MET groups." | 5.62 | The effect of dapsone in testosterone enanthate-induced polycystic ovary syndrome in rat. ( Dehpour, AR; Khaledi, E; Khazaei, M; Noori, T; Sadeghi, F; Shirooie, S; Sobarzo-Sánchez, E, 2021) |
| "Dapsone has been shown to possess anti-inflammatory activity in a variety of animal models." | 5.26 | The anti-inflammatory profile of dapsone in animal models of inflammation. ( Gemmell, DK; Lewis, AJ; Stimson, WH, 1978) |
| "Dapsone exerts cardioprotective effects on doxorubicin-induced cardiotoxicity through its anti-inflammatory and antioxidant mechanism." | 3.96 | Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats. ( Dehpour, AR; Emami, AH; Faghir-Ghanesefat, H; Nezamoleslami, S; Sheibani, M, 2020) |
| "Phenotypic activity of these two routes of metabolism was assessed in 18 patients receiving longterm dapsone therapy for inflammatory dermatoses and was related to the development of dapsone toxicity." | 3.70 | Development of dapsone toxicity in patients with inflammatory dermatoses: activity of acetylation and hydroxylation of dapsone as risk factors. ( Adedoyin, A; Bluhm, RE; Branch, RA; McCarver, DG, 1999) |
| " BACKGROUND: Acne vulgaris has varying physical and psychological effects in men and women of different ages, races, and ethnicities." | 2.84 | Treatment Response With Once-Daily Topical Dapsone Gel, 7.5% for Acne Vulgaris: Subgroup Analysis of Pooled Data from Two Randomized, Double-Blind Stu. ( Berk, DR; Bruce, S; Chang-Lin, JE; Downie, J; Draelos, ZD; Kaoukhov, A; Kempers, SE; Peredo, MI; Rodriguez, DA; Ruan, S, 2017) |
| "Recognition that acne is an inflammatory condition, not an infectious one, has led to a call for reduction in antibiotic use." | 2.61 | An Overview of Acne Therapy, Part 1: Topical therapy, Oral Antibiotics, Laser and Light Therapy, and Dietary Interventions. ( Baldwin, HE; Marson, JW, 2019) |
| "Treatment with dapsone and metformin reversed the effects of testosterone in the DAP and MET groups." | 1.62 | The effect of dapsone in testosterone enanthate-induced polycystic ovary syndrome in rat. ( Dehpour, AR; Khaledi, E; Khazaei, M; Noori, T; Sadeghi, F; Shirooie, S; Sobarzo-Sánchez, E, 2021) |
| "Acute myeloid leukemia was the most common malignancy (in 24 of 83 patients [29%])." | 1.48 | Sweet syndrome in patients with and without malignancy: A retrospective analysis of 83 patients from a tertiary academic referral center. ( Ashchyan, HJ; Gowda, A; James, WD; McMahon, CM; Micheletti, RG; Nelson, CA; Noe, MH; Perl, AE; Rosenbach, M; Wu, B, 2018) |
| " dapsone, nimesulide and sulphapyridine, have the potential to reduce the bioavailability of neutrophil-derived HOCl and, in turn, to favour the alpha 1-antitrypsin-dependent control of neutrophil elastolytic activity." | 1.29 | Sulphonamides as anti-inflammatory agents: old drugs for new therapeutic strategies in neutrophilic inflammation? ( Balbi, A; Bevilacqua, M; Dallegri, F; Dapino, P; Ottonello, L; Scirocco, MC, 1995) |
| "Dapsone has been examined by two established animal anti-inflammatory models and found to possess anti-inflammatory activity comparable with established non-steroidal anti-inflammatory drugs." | 1.26 | Anti-inflammatory actions of dapsone and its related biochemistry. ( Best, R; Capstick, RB; Lewis, DA; Williams, K, 1976) |
| "Dapsone has been shown to possess anti-inflammatory activity in a variety of animal models." | 1.26 | The anti-inflammatory profile of dapsone in animal models of inflammation. ( Gemmell, DK; Lewis, AJ; Stimson, WH, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (33.33) | 18.7374 |
| 1990's | 3 (14.29) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 8 (38.10) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Saunders, MJ | 1 |
| Edwards, BS | 1 |
| Zhu, J | 1 |
| Sklar, LA | 1 |
| Graves, SW | 1 |
| Galijasevic, S | 1 |
| McLarnon, JG | 1 |
| Sheibani, M | 1 |
| Nezamoleslami, S | 1 |
| Faghir-Ghanesefat, H | 1 |
| Emami, AH | 1 |
| Dehpour, AR | 2 |
| Shirooie, S | 1 |
| Khaledi, E | 1 |
| Noori, T | 1 |
| Khazaei, M | 1 |
| Sadeghi, F | 1 |
| Sobarzo-Sánchez, E | 1 |
| Draelos, ZD | 1 |
| Rodriguez, DA | 1 |
| Kempers, SE | 1 |
| Bruce, S | 1 |
| Peredo, MI | 1 |
| Downie, J | 1 |
| Chang-Lin, JE | 1 |
| Berk, DR | 1 |
| Ruan, S | 1 |
| Kaoukhov, A | 1 |
| Nelson, CA | 1 |
| Noe, MH | 1 |
| McMahon, CM | 1 |
| Gowda, A | 1 |
| Wu, B | 1 |
| Ashchyan, HJ | 1 |
| Perl, AE | 1 |
| James, WD | 1 |
| Micheletti, RG | 1 |
| Rosenbach, M | 1 |
| Geyfman, M | 1 |
| Debabov, D | 1 |
| Poloso, N | 1 |
| Alvandi, N | 1 |
| Marson, JW | 1 |
| Baldwin, HE | 1 |
| Bhat, YJ | 1 |
| Hassan, I | 1 |
| Sajad, P | 1 |
| Akhtar, S | 1 |
| Sheikh, S | 1 |
| Chawla, S | 1 |
| Smart, CJ | 1 |
| Moots, RJ | 1 |
| Davies, P | 1 |
| Bonney, RJ | 1 |
| Humes, JL | 1 |
| Kuehl, FA | 1 |
| Guill, MA | 1 |
| Aton, JK | 1 |
| Ottonello, L | 1 |
| Dapino, P | 1 |
| Scirocco, MC | 1 |
| Balbi, A | 1 |
| Bevilacqua, M | 1 |
| Dallegri, F | 1 |
| Cairns, BA | 1 |
| Herbst, CA | 1 |
| Sartor, BR | 1 |
| Briggaman, RA | 1 |
| Koruda, MJ | 1 |
| Bluhm, RE | 1 |
| Adedoyin, A | 1 |
| McCarver, DG | 1 |
| Branch, RA | 1 |
| Williams, K | 1 |
| Capstick, RB | 1 |
| Lewis, DA | 1 |
| Best, R | 1 |
| Lewis, AJ | 2 |
| Gemmell, DK | 2 |
| Stimson, WH | 2 |
| Jampol, LM | 1 |
| West, C | 1 |
| Goldberg, MF | 1 |
| Maloff, BL | 1 |
| Fox, D | 1 |
| Bruin, E | 1 |
| Di Meo, TM | 1 |
4 reviews available for dapsone and Inflammation
| Article | Year |
|---|---|
The development of myeloperoxidase inhibitors.
Topics: Animals; Enzyme Inhibitors; Humans; Inflammation; Molecular Structure; Monocytes; Neutrophils; Perox | 2019 |
Consideration of a Pharmacological Combinatorial Approach to Inhibit Chronic Inflammation in Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Dapsone; Drug Therapy, Combination; Humans; Ibuprofen; Inflammation; Min | 2019 |
An Overview of Acne Therapy, Part 1: Topical therapy, Oral Antibiotics, Laser and Light Therapy, and Dietary Interventions.
Topics: Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Anti-Bacterial Agents; Combined Moda | 2019 |
Peristomal pyoderma gangrenosum and inflammatory bowel disease.
Topics: Adolescent; Adult; Biopsy; Colostomy; Crohn Disease; Dapsone; Female; Humans; Ileostomy; Inflammatio | 1994 |
1 trial available for dapsone and Inflammation
| Article | Year |
|---|---|
Treatment Response With Once-Daily Topical Dapsone Gel, 7.5% for Acne Vulgaris: Subgroup Analysis of Pooled Data from Two Randomized, Double-Blind Stu.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Age Factors; Child; Dapsone; Dermatologic Agents | 2017 |
16 other studies available for dapsone and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Pr | 2010 |
Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cardiotoxicity; Cytokines; Dapsone; Doxo | 2020 |
The effect of dapsone in testosterone enanthate-induced polycystic ovary syndrome in rat.
Topics: Androgens; Animals; Cytokines; Dapsone; Female; Inflammation; Metformin; Ovary; Polycystic Ovary Syn | 2021 |
Sweet syndrome in patients with and without malignancy: A retrospective analysis of 83 patients from a tertiary academic referral center.
Topics: Academic Medical Centers; Adrenal Cortex Hormones; Adult; Aged; Anemia; Arthralgia; Colchicine; Daps | 2018 |
Mechanistic insight into the activity of a sulfone compound dapsone on Propionibacterium (Newly Reclassified as Cutibacterium) Acnes-mediated cytokine production.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Cell Prolifer | 2019 |
Sweet's Syndrome: An Evidence-Based Report.
Topics: Adrenal Cortex Hormones; Adult; Anti-Infective Agents; Dapsone; Female; Humans; Inflammation; Leukoc | 2015 |
Recto-vaginal fistula: a refractory complication of Behcet's disease.
Topics: Adult; Antibodies, Monoclonal; Behcet Syndrome; Dapsone; Disease Progression; Female; Humans; Inflam | 2007 |
The role of macrophage secretory products in chronic inflammatory processes.
Topics: Animals; Anti-Inflammatory Agents; Arachidonic Acids; Cell Division; Complement System Proteins; Dap | 1980 |
Facial granuloma responsive to dapsone therapy.
Topics: Adult; Dapsone; Facial Dermatoses; Female; Granuloma; Humans; Inflammation | 1982 |
Sulphonamides as anti-inflammatory agents: old drugs for new therapeutic strategies in neutrophilic inflammation?
Topics: alpha 1-Antitrypsin; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultu | 1995 |
Development of dapsone toxicity in patients with inflammatory dermatoses: activity of acetylation and hydroxylation of dapsone as risk factors.
Topics: Acetylation; Adult; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Female; Gangrene; Humans; Hydr | 1999 |
Anti-inflammatory actions of dapsone and its related biochemistry.
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Dapsone; Erythrocytes; Female; Guinea Pigs; In Vitro T | 1976 |
The anti-inflammatory profile of dapsone in animal models of inflammation.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; | 1978 |
Studies on the anti-inflammatory properties of dapsone in a variety of animal models [proceedings].
Topics: Animals; Anti-Inflammatory Agents; Dapsone; Female; Guinea Pigs; Inflammation; Male; Rats; Rats, Inb | 1977 |
Therapy of scleritis with cytotoxic agents.
Topics: Adult; Antineoplastic Agents; Cyclophosphamide; Dapsone; Drug Therapy, Combination; Eye Diseases; Fe | 1978 |
Dapsone inhibits LTB4 binding and bioresponse at the cellular and physiologic levels.
Topics: Animals; Chemotaxis, Leukocyte; Dapsone; Female; Humans; In Vitro Techniques; Inflammation; Leukotri | 1988 |